We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Vaccine Manufacture and Supply – News and Features

News

Vaccine Research Summit

Novel technologies have boosted the vaccines industry worldwide. Recent technological advances in vaccine research, indicate a promising future for the new generation of vaccines.
News

CEVEC Raises €6M to Grow CAP® Technology Based Protein and Vaccine Business

CEVEC announces closing of €6M financing round.
News

VacChina 2011- The Largest China’s Vaccine Meeting

The meeting welcomes world class biotechs and pharmas to discuss the opportunities of development of novel vaccine R&D and manufacturing technologies in China.
News

Adaptimmune Announces Opening of Phase I/II Clinical Trial for Metastatic Melanoma

The Phase I/II, two cohort, open label clinical trial in metastatic melanoma opens at Washington University, St. Louis, Missouri.
News

Adaptimmune Announces Opening of Phase I/II Clinical Trial in Multiple Myeloma

Trial could generate future alternative treatment for multiple myeloma.
News

Watson’s Eden Biodesign and Crucell Sign Vendor Network Agreement Facilitating Access to cGMP Manufacturing Services for Vaccines and Gene Therapies Using PER.C6® Cell Line Technology

Eden Biodesign Ltd. today announced the execution of a non-exclusive Vendor Network Agreement with Crucell, under which Eden Biodesign has become a pre-approved authorized provider of process development and cGMP manufacturing services using Crucell’s proprietary PER.C6® cell line technology. Under the terms of the agreement Eden Biodesign will be able to offer its services to Crucell’s PER.C6® licensees in the field of vaccines and gene therapy.
News

IDT Biologika Introduces Plans to Expand

IDT, a global integrated contract manufacturer of vaccines and biopharmaceuticals, has introduced plans to expand its Vaccine Capacity and Workforce.
News

CAP Cells Suitable for Commercial Vaccine Production?

CEVEC Pharmaceuticals has announced that CAP cells produce high virus titers upon infection with influenza strains.
News

Novozymes Announces Master File for Recombinant Albumin

The dossier, containing information on the manufacture and safety of albucult, can help support the medical devices and drug formulation applications.
News

Novozymes Showcases Biopharmaceutical Solutions at BioProcess International 2010

The Company plans to feature its range of regulatory compliant, recombinant and animal-free products and technologies at the annual conference.
Advertisement